EXELIXIS, INC. — Director's Dealing 2012

Dec 10, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2012-12-10

Reporting Person: Schwab Gisela (EVP and Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-12-10	Common Stock	P	25000	$4.39	Acquired	56874	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4774	Indirect

Footnotes

F1: Represents 4,774 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of December 7, 2012.